Use of nimesulide in children [9]

Lancet

Volumn 354, Issue 9183, 1999, Pages 1034-

  Addis, A ^a   Bonati, M ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRONE; IBUPROFEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

CHILD; DRUG LEGISLATION; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; HUMAN; ISRAEL; ITALY; LETTER; LIVER FAILURE; PEDIATRICS; PORTUGAL; PRIORITY JOURNAL; REYE SYNDROME; RISK BENEFIT ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG APPROVAL; DRUG LABELING; NOTE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CYCLOOXYGENASE INHIBITORS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG APPROVAL; DRUG LABELING; HUMANS; SULFONAMIDES;

EID: 0033581279     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)76642-3     Document Type: Letter

References (4)

1. K Weerasuriya Registration of new drugs in developing countries Lancet 353 1999 2161 2162
2. Portugal suspends paediatric nimesulide Scrip 2431 1999 20
3. J McIntyre D Hull Comparative efficacy and tolerability of ibuprofen and paracetamol in fever Arch Dis Child 74 1996 164 167
4. A Bennett Nimesulide: a multifactorial therapeutic approach to the inflammatory process? A 7 year clinical experience Drugs 46 suppl 1 1993 xV